N asal obstruction may be important in the pathogenesis of obstructive sleep apnea (OSA). Normal subjects breathe almost exclusively via the nasal airway during quiet wakefulness and sleep (1) . Snorers and patients with OSA tend to have a higher nasal resistance than normal subjects (2) and mouth breathe to a greater extent during sleep (3) . If the nasal airway is occluded in normal subjects, thus forcing mouth breathing during sleep, OSA invariably ensues (4, 5) , and this tendency to OSA is markedly increased with even partial nasal obstruction (6, 7) . It follows that relief of nasal obstruction should significantly reduce the tendency to OSA.
Perhaps the simplest way of improving the nasal airway is to mechanically dilate the nasal valve area, the site of minimum cross-sectional area in the normal nose. Four studies have examined the effect of nasal valve dilation on OSA severity. In a double-blind, crossover design, Bahammam and colleagues (8) evaluated the efficacy of a Breathe Right (CNS Inc, USA) external nasal dilator strip in 18 patients with upper airway resistance syndrome. The use of the Breathe Right nasal strip was associated with objective improvement in anterior nasal cross-sectional area as measured by acoustic rhinometry, but not with any improvement in the apnea-hypopnea index (AHI). Snoring was not measured in that study. Among 12 nonobese patients with chronic rhinitis, Pevernagie and colleagues (9) reported no change in AHI, sleep architecture or maximum snoring intensity with the Breathe Right nasal strip, but there was a mean 33% reduction in snoring frequency associated with use of the strip. One study demonstrated a reduction in both the frequency and intensity of snoring with the Breathe Right strip in 22 of 30 subjects (10) . Interestingly, in the latter study, the device was associated with reduced snoring in stages 1 and 2 of nonrapid eye movement sleep, but not in slow-wave or rapid eye movement sleep. Schonhofer and colleagues (11) evaluated the Nozovent (Scandinavian Naturals, USA) device (a plastic splint designed to sit inside the nostrils and widen the nasal valve by exerting lateral pressure on the nasal walls) in 26 patients with moderate or severe OSA. They reported no significant change in the AHI or sleep architecture with the device among the 21 patients who completed the study.
Medication can also be used to improve nasal obstruction in patients with OSA. Kerr and colleagues (12) used a randomized crossover study design to compare the effect of topical nasal decongestant in combination with stenting of the nasal vestibule with placebo (saline nose drops) in patients with OSA. The active treatment was associated with a reduced arousal frequency but no improvement in the other polysomnographic variables -sleep architecture, AHI or oxygen saturation. Similarly, the use of a nasal decongestant did not result in any improvement in either the AHI or snoring in 20 asymptomatic individuals with mild OSA (13) . However, among 20 patients with allergic rhinitis, topical nasal corticosteroid was associated with a significant subjective improvement in nasal congestion and sleep quality (no objective polysomnographic measurements were made in this study) (14) .
In evaluating the impact of nasal surgeries on snoring and sleep apnea, it is important to note that there have been no randomized, controlled studies in this area. Several different surgical strategies to improve the nasal airway of patients with OSA have been applied, including nasal valve reconstruction, septoplasty and turbinate mucosal reduction. The reported results of nasal surgery for OSA have been highly variable from one study to the next (15) (16) (17) (18) (19) (20) (21) . In general, although nasal surgery tended to reduce subjective snoring severity in a fairly consistent manner across these studies, its effect on sleep apnea severity was highly variable. Series and colleagues (22) objectively measured both the change in nasal resistance and the change in sleep apnea severity postnasal surgery and correlated the outcome with cephalometric measurements of the upper airway. Although their two groups experienced a similar (mean 50%) fall in nasal resistance postoperatively, the group that experienced significant improvement in sleep apnea severity postsurgery had different cephalometric characteristics (increased posterior airway space and mandibular plane to hyoid bone distance) to the nonresponders. No one has used these measurements prospectively to successfully predict the outcome of nasal surgery for OSA, however.
In summary, available literature is consistent in demonstrating an increased tendency to OSA in association with nasal obstruction, but the reported efficacy of relief of nasal obstruction as a treatment for OSA is highly variable and, in general, rather disappointing. Relatively few studies have objectively measured the efficacy of the treatment used to reduce nasal resistance, which makes it difficult to discern whether the failure to elicit improvement in snoring or OSA in those studies reflects an ineffective therapy or a bona fide treatment failure.
